ZVSAZyVersa Therapeutics Inc

$0.17
$0.00
(0.00%)
Today
Updated: 01:03 PM EDT
EarningsAug 13
Mkt Cap$1.38M
Vol415.00
News
all
press releases
News Placeholder
Retail Traders Flock To ZyVersa As IC 100 Obesity Plan Looks To Fill GLP-1 Gaps
ZyVersa's IC 100 strategy focuses on targeting inflammasome-driven inflammation to enhance weight loss and improve metabolic function in obesity patients.
Stocktwits
<
...
1
>
Top Discussions

Advertisement|Remove ads.